Seven Biopharma Companies Form Neuroscience Consortium
Seven biopharmaceutical firms, including Marlborough-based Sunovion Pharmaceuticals, will join to form the Massachusetts Neuroscience Consortium.
Announced today at the 2012 BIO International Convention in Boston, the consortium will fund pre-clinical neuroscience at Massachusetts academic and research institutions.
The other participating companies are Abbott Laboratories – which has a facility in Worcester, Biogen Idec, EMD Serono, Janssen Research & Development, Merck and Pfizer.
According to a statement from the Patrick Administration, the consortium is a new model that is designed to leverage Massachusetts’ rich environment for accelerating early-stage research available to the pharmaceutical industry, introducing academic researchers to the challenges of targeted research, and facilitating industry-academic collaborations. Project results and tools developed will be shared with all participants.
Each participating company has pledged to contribute $250,000 to the consortium, for total initial funding of $1.75 million. They will solicit and review proposals from academic research institutions for pre-clinical neuroscience research. All Massachusetts academic and research institutions will be eligible to apply for grant funding through the consortium.
Read more
Sunovion Acquires San Diego Biopharma Company
Mass. Biopharma Jobs Hit New High, Account For $6B In Payroll
WBJ Web Partners
Most Recent
Most Recent
0 Comments